EGFR and adenocarcinoma: Second biopsy after cytotoxic chemotherapy for SCLC with an EGFR mutation revealed transformation to adenocarcinoma in various reports[8,11], indicating that the SCLC component is more sensitive to cytotoxic chemotherapy than the adenocarcinoma component.